drugset / Trial / NCT02815722

The Drug-drug Interaction of SP2086 and Simvastatin

NCT02815722

Phase 1 Completed 16 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to investigate the potential interaction between SP2086 and Simvastatin after the multiple oral doses treatment in healthy adult volunteers.

Timeline

Start
2013-07
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Retagliptin Small molecule 200 mg Oral
Comparator Simvastatin Small molecule 40 mg Oral